The article was written by Motek Moyen ResearchSeeking Alpha’s #1 Writer on Long Ideas and #2 in Technology – Senior Analyst at I Know First.
Summary:
Ignore the noise/anxiety over China’s threat to file anti-trust charges against DRAM leaders like Micron. It is just China making retaliatory threats against Trump’s trade war words.
Better focus on the fact that mobile DRAM sales continue to surge. Growing mobile DRAM demand can offset declining prices of PC DRAM products.
Apple’s choice of Micron DRAM for its latest iPhones is a solid tailwind for Micron. Apple’s track record showed it can sell more than 50 million new iPhones per year.
Micron’s mass production of 10-nm 12GB LPDDR4X mobile DRAM should keep Apple as a customer for a long time.
MU has obvious notable upside potential because its valuation is way below than that of its peers in the semiconductor industry.
The purpose of this report is to present the results of live forecast performance evaluation for I Know First AI Algorithm, specifically for Singaporean stock market. The following results were observed when signal and predictability filters were applied in order to pick the best performing stocks out of the most predictable ones. The period under evaluation is from January 3rd,2018 to September 30th, 2018. The corresponding returns distribution of stock filters (stocks subsets) for both Singaporean stock market universe and the main findings are below:
Singaporean Stock Market Universe Highlights:
Signal indicator filter applied to Top 30 most predictable stocks provides the highest return of 4.66% for Top 5 stocks on 3-months’ investment horizon
There is a clear increasing trend for returns improvement with the time horizon increase – the delta in returns from 1 month to 3 months is more than 350% for Top 5 stocks
Top 5 stocks significantly out-perform the benchmark by over 210%
The above results were obtained based on forecasts’ evaluation over the specific time period using consecutive filtering approach – by predictability, then by signal, to give general overview of the forecasting capabilities of the algorithm for specific stock universe.
Over the past month Clinuvel Pharmaceuticals Limited (CUV.AX) saw a rise of 49.19% this marks it as the biggest earner within Australian Stock as I Know First predicted. This surge can be attributed to the anticipated FDA approval for its drug SCENESSE® a photo-protective drug used to treat a rare condition known as targeting erythropoietic protoporphyria (EPP). SCENESSE® is already approved by the EU in 2014 and was available from 2016 across Europe. In the first half of FY18, Clinuvel had revenue of just $7 million, enough to generate
This week ACAD saw a 52.38% jump, being the 7 day forecast’s biggest earner, as the I Know First algorithm predicted. Before this week, ACAD’s shares have been under pressure from what turned out to be an inaccurate report from CNN. Acadia Pharmaceuticals is again bringing in impressive returns. The drug under fire was Nuplazid. The FDA only recently discarded these allegations to be untrue. Nuplazid made up $57.1 million in sales Q2 for ACAD, an 18% increase from the first quarter. Sales of the drug are increasing 87% year over year. The
In this live forecast evaluation report we will examine the performance of the forecasts generated by the I Know First AI Algorithm for the Indian stock market and sent to our customers on a daily basis. Our analysis covers time period from March 1, 2018 to August 24, 2018.We will start with an introduction to our stock picking and benchmarking methods and then apply it to the stock universe of the Nifty 200 index as well as all of the stocks covered by us in the “Indian Stocks” Package.
American Outdoor Brands Corporation (AOBC) has seen a large surge of success over the past couple of weeks. After seeing a 84% decline in their net income in 2018, coming down to $20 million. Firearm sales which are the core of the brand (AOBC also being known as the iconic arms brand Smith & Wesson), were down 41.9%. The decline in gun sales began with a push for tighter gun control laws in America, and took a steeper drop around election time. However, sales are once again looking to be on a healthy incline. It should be noted that the company also expanded out of
I Know First-Daily Market Forecast, does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, stock forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.
